What is the creatinine clearance for a 68‑year‑old male who weighs 80 kg and has a serum creatinine of 1.2 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Creatinine Clearance Calculation for a 68-Year-Old Male

For this 68-year-old male weighing 80 kg with a serum creatinine of 1.2 mg/dL, the estimated creatinine clearance is approximately 65 mL/min using the Cockcroft-Gault formula, indicating Stage 2 chronic kidney disease that requires careful medication review and dose adjustment for renally cleared drugs. 1

Step-by-Step Calculation

Using the Cockcroft-Gault Formula:

The formula is: CrCl (mL/min) = [(140 - age) × weight (kg)] / [72 × serum creatinine (mg/dL)] 1

  • Age: 68 years
  • Weight: 80 kg
  • Serum creatinine: 1.2 mg/dL
  • Sex factor: 1.0 (male; would be × 0.85 if female) 1

Calculation:

  • CrCl = [(140 - 68) × 80] / [72 × 1.2]
  • CrCl = [72 × 80] / 86.4
  • CrCl = 5,760 / 86.4
  • CrCl ≈ 67 mL/min 1

Clinical Interpretation

  • This creatinine clearance of ~67 mL/min represents Stage 2 CKD (GFR 60-89 mL/min/1.73 m²), indicating mildly decreased kidney function. 2

  • Critical insight: A serum creatinine of 1.2 mg/dL appears "normal" (upper limit ~1.4 mg/dL) but actually represents significant age-related renal impairment in this 68-year-old patient. 1, 3 The same creatinine value would correspond to a CrCl of ~110 mL/min in a young adult but only ~40-67 mL/min in an elderly patient. 1

  • Never use serum creatinine alone to assess kidney function—the K/DOQI guidelines explicitly prohibit this practice because it markedly underestimates renal insufficiency, particularly in elderly patients with reduced muscle mass. 1, 2, 3

Medication Management Implications

  • All renally cleared medications require dose review at this level of renal function. 2 Many drugs need adjustment when CrCl falls below 70-80 mL/min, even though this patient is only in Stage 2 CKD. 2

  • Calculate creatinine clearance before initiating any nephrotoxic medications (aminoglycosides, vancomycin, NSAIDs, contrast agents). 2

  • The Cockcroft-Gault formula is specifically recommended for medication dosing decisions because most pharmacokinetic studies and FDA drug labels reference this formula, not MDRD or CKD-EPI equations. 1, 2

Important Caveats and Limitations

  • The Cockcroft-Gault formula systematically underestimates true GFR in elderly patients, with the greatest discrepancy in the oldest age groups. 1 This means the actual renal function may be somewhat better than calculated.

  • However, at CrCl levels around 60-70 mL/min, the formula may also overestimate true GFR because tubular secretion of creatinine increases as kidney function declines. 1 These opposing biases partially offset each other in this patient.

  • For drugs with narrow therapeutic indices (vancomycin, aminoglycosides, digoxin, lithium, chemotherapy), consider cystatin C-based equations or direct GFR measurement using exogenous markers for higher precision. 1

  • If this patient were obese (BMI ≥ 30 kg/m²), use the mean of actual body weight and ideal body weight in the Cockcroft-Gault formula for improved accuracy. 1, 4

Alternative Assessment Methods

  • For CKD diagnosis and staging (rather than medication dosing), the MDRD or CKD-EPI equations are more appropriate because they provide GFR indexed to body surface area (mL/min/1.73 m²). 1, 2

  • The MDRD formula would yield: eGFR = 186 × (1.2)^-1.154 × (68)^-0.203 ≈ 60-65 mL/min/1.73 m², confirming Stage 2 CKD. 1

  • Direct GFR measurement with exogenous markers (inulin, iohexol) is reserved for situations requiring precise GFR determination, such as glomerular diseases requiring immunosuppression or when calculated values seem inconsistent with clinical presentation. 1

References

Guideline

Estimating Creatinine Clearance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Chronic Kidney Disease Assessment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Creatinine Clearance Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.